CSIMarket
 
Xenetic Biosciences Inc   (NASDAQ: XBIO)
 

Xenetic Biosciences Inc's Customers Performance

XBIO



 
XBIO's Source of Revenues During the corresponding time, Xenetic Biosciences Inc recorded a revenue increase by 11.99 % year on year, sequentially revenue fell by -18.13 %. While revenue at the Xenetic Biosciences Inc 's corporate clients

List of XBIO Customers




for the same period Xenetic Biosciences Inc recorded revenue increase by 11.99 % year on year, sequentially revenue fell by -18.13 %.

List of XBIO Customers

Xenetic Biosciences Inc's Business Units
Royalty Revenue    222.09 % of total Revenue






Xenetic Biosciences Inc's Comment on Sales, Marketing and Customers



The company serves customers including the Veterans Administration, Department of Defense (covering military personnel and dependents through the TRICARE retail pharmacy program), Coast Guard, and Public Health Service (PHS). Drug pricing for these entities is subject to federal ceiling price caps and may include additional discounts. The company also provides discounts to hospitals serving financially needy patients, community health clinics, and other organizations receiving health services grants from the PHS. Its market is influenced by government healthcare programs such as the Medicaid Drug Rebate Program and Medicare Part D, as well as legislation including the Affordable Care Act and related political and judicial actions affecting healthcare funding and drug pricing.





Xenetic Biosciences Inc’s Comment on Sales, Marketing and Customers


The company serves customers including the Veterans Administration, Department of Defense (covering military personnel and dependents through the TRICARE retail pharmacy program), Coast Guard, and Public Health Service (PHS). Drug pricing for these entities is subject to federal ceiling price caps and may include additional discounts. The company also provides discounts to hospitals serving financially needy patients, community health clinics, and other organizations receiving health services grants from the PHS. Its market is influenced by government healthcare programs such as the Medicaid Drug Rebate Program and Medicare Part D, as well as legislation including the Affordable Care Act and related political and judicial actions affecting healthcare funding and drug pricing.








XBIO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Xenetic Biosciences Inc 5.27 3.19 -2.23 2
SUBTOTAL 0.00 0.00 0.00 -

Sources: Xenetic Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Xenetic Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Xenetic Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.